Literature DB >> 10197373

Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group.

W Zou1, A Foussat, S Houhou, I Durand-Gasselin, A Dulioust, L Bouchet, P Galanaud, Y Levy, D Emilie.   

Abstract

BACKGROUND: The treatment of HIV-infected patients with interleukin (IL)-2 causes a sustained increase in CD4+ T-lymphocyte counts, involving both naive and memory cells. However, the short-term immunological effects of IL-2, which may shed light on the mechanism of immune reconstitution by this cytokine, are unknown.
OBJECTIVE: To evaluate the acute effect of IL-2 on circulating T-lymphocyte subpopulations and their expression of chemokine receptors. DESIGN AND METHODS: Flow cytometry, reverse transcriptase polymerase chain reaction and chemokine receptor function experiments were performed before and after 5 days of IL-2 administration in 30 HIV-infected patients.
RESULTS: IL-2 induced an acute lymphopenia of both naive and memory T-helper (TH) lymphocytes. This was associated with a large increase in CC-chemokine receptor (CCR)-5 and CCR-2b expression by TH cells. Before IL-2 treatment, CCR-5 was mostly produced by CD62L- memory TH lymphocytes. After 5 days of IL-2 administration, the level of CCR-5 mRNA in circulating cells was 18.6 times higher than before treatment (P < 0.002). CCR-5 expression was upregulated in CD62L- memory TH lymphocytes, but also in CD62L+ memory and in naive (CD62L+ CD45RO-) TH lymphocytes. IL-2 treatment also increased the function of CCR-5 in TH cells.
CONCLUSIONS: Chemokine receptors are involved in trafficking of lymphocytes. The IL-2-induced upregulation of chemokine receptors in TH cells may thus play a role in the acute effects of this cytokine in TH lymphocyte redistribution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197373     DOI: 10.1097/00002030-199903110-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

Authors:  M Mengozzi; M Malipatlolla; S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  Effects of exogenous IL-2 administration on the homeostasis of CD4+ T lymphocytes.

Authors:  Arnaud Foussat; Laurence Bouchet-Delbos; Jacques Couderc; Dominique Berrebi; Michèle German-Fattal; Marie-Christine Maillot; Ingrid Durand-Gasselin; Pierre Galanaud; James P Di Santo; Dominique Emilie
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

3.  R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.

Authors:  Françoise Gondois-Rey; Angelique Biancotto; Marcelo Antonio Fernandez; Lise Bettendroffer; Jana Blazkova; Katerina Trejbalova; Marjorie Pion; Ivan Hirsch
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.

Authors:  P De Paoli; S Zanussi; L Caggiari; M T Bortolin; M D'Andrea; C Simonelli; U Tirelli
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

5.  Marked differences in CCR5 expression and activation levels in two South African populations.

Authors:  Anabela C P Picton; Sharon Shalekoff; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

6.  CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

7.  Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Authors:  M S Orandle; K C Williams; A G MacLean; S V Westmoreland; A A Lackner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Association of the CCR5 gene with juvenile idiopathic arthritis.

Authors:  A Hinks; P Martin; E Flynn; S Eyre; J Packham; A Barton; J Worthington; W Thomson
Journal:  Genes Immun       Date:  2010-05-13       Impact factor: 2.676

9.  CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

Authors:  Jose F Camargo; Marlon P Quinones; Srinivas Mummidi; Sowmya Srinivas; Alvaro A Gaitan; Kazi Begum; Fabio Jimenez; Scott VanCompernolle; Derya Unutmaz; Seema S Ahuja; Sunil K Ahuja
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  IL-2 immunotherapy in chronically SIV-infected Rhesus macaques.

Authors:  Julie Garibal; Mireille Laforge; Ricardo Silvestre; Shahul Mouhamad; Laure Campillo-Gimenez; Yves Lévy; Jérôme Estaquier
Journal:  Virol J       Date:  2012-09-28       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.